NCT07426484 2026-02-23Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic MalignancyDana-Farber Cancer InstitutePhase 4 Not yet recruiting80 enrolled
NCT07424833 2026-02-20A Study of APG-3288 in Relapsed/Refractory Blood CancersAscentage Pharma Group Inc.Phase 1 Not yet recruiting180 enrolled